✦ LIBER ✦

Modified vincristine, doxorubicin, and dexamethasone regimen in the treatment of resistant or relapsed chronic lymphocytic leukemia an eastern cooperative oncology group study

✍ Scribed by William R. Friedenberg; Janet Anderson; Barbara C. Wolf; Peter A. Cassileth; Martin M. Oken

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 735 KB
Volume: 71
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19930515)71:10<2983::aid-cncr2820711016>3.0.co;2-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High dose chlorambucil versus Binet's mo

High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia : Results of an international multicenter randomized trial

✍ Branimir Jaksic; Maura Brugiatelli; Ivo Krc; Hajna Losonczi; Jerzy Holowiecki; A 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

vanced and/or progressive disease was defined by high Total Tumor Mass (TTM) score (ú9), and/or short doubling time (DT) (õ12 months), and/or bone marrow for the International Society for Chemo-Immunotherapy, Vienna failure. The response to therapy was defined by reduction of the initial TTM score.

Phase III study of PSC-833 (valspodar) i

Phase III study of PSC-833 (valspodar) in combination with vincristine, doxorubicin, and dexamethasone (valspodar/VAD) versus VAD alone in patients with recurring or refractory multiple myeloma (E1A95) : A trial of the Eastern Cooperative Oncology Group

✍ William R. Friedenberg; Montserrat Rue; Emily A. Blood; William S. Dalton; Chaim 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB 👁 1 views